ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RFG Roebuck Food Group Public Limited Company

12.75
0.00 (0.00%)
28 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Roebuck Food Group Public Limited Company LSE:RFG London Ordinary Share IE0006447985 ORD EUR0.025 (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 12.75 12.00 13.50 12.75 12.75 12.75 2,600 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Refrigerated Whse & Storage 26.74M -1.85M -0.0616 -2.07 3.83M

Roebuck Food Group PLC CHAIRMAN'S STATEMENT - FINAL RESULTS

28/03/2024 10:20am

RNS Regulatory News


RNS Number : 7065I
Roebuck Food Group PLC
28 March 2024
 

Chairman's Statement

 

Roebuck Food Group plc (AIM: RFG), is pleased to announce its results for the year ended 31 December 2023.

 

Group Financial Highlights - Continuing Operations

·    Group revenue decreased by 15% to £26.7m (2022: £31.4m)

·    Operating profit from continuing operations declined from £336,000 to a loss of £1,660,000 in the period under review.

·    The loss for the financial year from continuing operations amounted to £1,851,000. This compared to a profit of £156,000 in the prior year.

·    Earnings per share of (5.8)p on continuing operations (2022: 0.5p).

·    Significantly, net debt has decreased 71% from £3.44m in 2022 to £1m in 2023. Excluding IFRS 16, which reflects the lease obligations on Cantwellscourt Farm and Moorhead McGavin Limited to be classifed as debt, net debt at end 2023 was zero.

·    Strategic acquisition on 30 November 2023 of Moorhead and McGavin Limited, a specialty supplier of pules, cereals, pasta and rice to the food service industry.

 

Divisional Highlights - Continuing Operations

 

£'000

Sourcing

Dairy


2023

2022

2023

2022

2023

2022

Revenue

24.8

29.9

1.4

1.5

0.5

-

EBITDA

(0.2)

0.4

(0.1)

0.5

0.2

-

Operating Profit/(loss)

(0.3)

0.4

(0.4)

0.3

 

0.1

 

-

Operating Margin

(1.21)%

1.3%

(29)%

20%

 

20%

 

 

-

 

Sourcing Division

 

Post Brexit, Townview Foods (which forms the main part of our sourcing division) had to reset. Management delivered a more diversified business, trading across 41 countries internationally. We are now evolving the business further. We are in the process of revising the business model, which will involve changing our sales model and broadening the product offering, which in turn will give us access to new customers and new markets.  We believe this will provide the basis of a more durable business model.   This transition has required a significant investment in people which has more than offset the net profit growth to date.

 

Sales at our sourcing division decreased by 17% in 2023, compared with the same period in 2022, from £29.9m to £24.8m. The board decided to reduce trade to South Africa due to receivable recovery risks. Sales to South Africa decreased £4.3m from £5.1m in 2022 to £0.8m in 2023. Operating profit decreased from £0.4m to a loss of £0.3m.

 

 

 

 

Chairman's Statement (Continued)

Dairy Division

Notwithstanding a precipitous decline in dairy product prices, particularly in the second half of 2023, Cantwellscourt Farm managed to generate a small positive EBITDA before accounting for losses on biological assets. Reflecting the changes in nitrates rules, stock had to be sold into a very weak market resulting in an overall loss of £0.4m in the Diary Division.

Plant Protein And Ingredients Division

Moorhead & McGavin Limited (M&M) a business that was acquired 30 November 2023 specialises in supplying pulses, cereals, pasta and rice to the food service industry. The business delivered sales of £0.54m and an EBITDA of £0.1m in the first trading month since acquisition.

Outlook

We have largely now reset our key remaining business from Norish Plc; Townview Foods, Townview Sourcing and Cantwellscourt Farm. We expect to see improvement in all businesses as we move through 2024.

 

Moorhead & McGavin Limited (M&M), which was acquired 30 November 2023, continues to grow strongly. We look forward to continue working with the team at M&M to grow the business both organically and by acquisition. I would like to thank all at M&M for their commitment and loyalty to M&M and subsequently Roebuck Food Group, in the period during and post-acquisition.

 

Management at Roebuck Food Group have spent a lot of time looking at acquisition opportunities in the space defined by the need to feed a growing world population, with less land, water and with a lower carbon footprint. The inevitable disruption which will be caused by these seemingly differing needs will create opportunity. At this juncture we believe that we can build a business of significant size and scale over the next number of years in the best interest of all of the stakeholders of the company. Inevitably this will likely involve further issuance of equity. It goes without saying that we remain focused on delivering shareholder value through efficient capital allocation.

Dividend

The board does not recommend the payment of a dividend.

 

On behalf of the board, I would like to thank the management team and staff for their commitment and contribution in 2023.

 

 

Ted O'Neill

28 March 2024

 

 

 

Chairman's Statement (Continued)

Financial Review

Sales

Total Group revenue from continuing operations decreased by 15% to £26.7m (2022: £31.4m). Revenues in the Product Sourcing division (Townview Foods Ltd and Townview Sourcing Ltd) decreased by 17% to £24.8m (2022: £29.9m). Revenues in the Agri division (Cantwellscourt Farm Ltd) decreased by 6.67% to £1.4m (2022: £1.5m). The newly acquired Plant Protein and Ingredients division contributed £0.54m to revenues following the acquisition of Moorhead & McGavin Limited on 30 November 2023.

 

Gross (loss)/profit

 

Gross (loss)/profit from continuing activities £32k (2022: profit £883k).

 

Operating loss/(profit)

 

Operating loss from continuing activities increased to £1.66m (2022: profit £0.3m).

 

Finance expense (net)

 

Net Finance expense increased to £0.14m (2022: £0.12m).

 

Loss from discontinued operations

 

Loss from discontinued operations £Nil (2022: £1.4m).

 

Earnings per share

 

The basic adjusted earnings per share from continuing operations decreased to (5.8)p (2022: 0.5p).

 

Net Debt

 

The net debt position is £0.98m (2022: £3.44m).

 

Share Capital

 

£2.5m (before expenses) was raised during the year by the issue of 18,518,514 new ordinary shares to fund the acquisition of Moorhead & McGavin Limited. A further £150,000 (before expenses) representing 1,071,428 new ordinary shares was issued as part of the purchase consideration for Moorhead & McGavin Limited.

 

 

 

 

 

 



 

Financial Review (Continued)

Dividend

 

The board does not recommend a payment of a dividend.


Treasury policy and management

The treasury function, which is managed centrally, handles all Group funding, debt, cash, working capital and foreign exchange exposures.  Group treasury policy concentrates on the minimisation of risk in all of the above areas and is overseen and approved by the Board. Speculative positions are not taken.

 

Financial risk management

 

The Group's financial instruments comprise borrowings, cash, and various items, such as trade receivables, trade payables etc., that arise directly from its operations.  The main purposes of the financial instruments not arising directly from operations is to raise finance for the Group's operations.

 

The Group may enter into derivative transactions such as interest rate swaps, caps or forward foreign currency transactions in order to minimise its risks.  The purpose of such transactions is to manage the interest rate and currency risks arising from the Group's operations and its sources of finance.  No such material transactions were entered into in either 2023 or 2022.

 

The main risks arising from the Group's financial instruments are interest rate risk, liquidity risk, credit risk and foreign exchange risk.  The Group's policies for managing each of these risks are summarised below.

 

Interest rate risk

 

The Group finances its operations through a mixture of retained profits, bank and other borrowings at both fixed and floating rates of interest and working capital.  The Group determines the level of borrowings at fixed rates of interest having regard to current market rates and future trends.  At the year-end there are £0.1m at a floating rate of 7.59% and £1.1m at a fixed rate of 7.3%.

 

Liquidity risk

 

The Group is in a net debt position of £1m. This is made up of cash of £1.2m, Invoice financing of £1.1m, term loans of £0.1m and leases of £1m.

 

Credit risk

 

The Group's policy is to minimise exposure to credit risk by performing the appropriate customer due diligence and monitoring the exposure to credit risk.

 

Foreign exchange risk

 

The Group's policy is to manage foreign exchange risk which arises principally in the product sourcing division. The Group does this by mainly purchasing Euros and US dollars at a fixed rate forward for cross currency transactions and using this rate in establishing a selling price for its goods in order to maintain an acceptable margin.

 

 

Gerard Murphy

Finance Director 



 

28th March 2024

Consolidated STATEMENT OF COMPREHENSIVE INCOME

 

for the financial year ended 31 December 2023


 

 

 

 

2023

2022


 

 

£'000

£'000

 





Continuing operations





Revenue



26,737

31,351

Cost of sales



(26,769)

(30,468)




 


Gross (loss)/profit



(32)

883




 


Fair value gain on biological assets



139

182

Administrative expenses



(1,189)

(729)

Acquisition and related costs



(578)

-




 


Operating (loss)/profit from continuing operations



(1,660)

336

 



 


Interest received



25

9

Finance expenses - lease interest



(28)

(28)

Finance expenses - interest on bank loans



(138)

(100)




 


(Loss)/profit on continuing activities before taxation



(1,801)

217




 





 


Income taxes - Corporation tax



(12)   

(40)

Income taxes - Deferred tax



(38)

(21)




 


(Loss)/profit for the financial year from continuing operations



(1,851)

156

 



 


Loss for the financial year from discontinued operations

 

 


-   

 

(1,404)

 



 


Loss for the financial year attributable to

owners of the parent



(1,851)

(1,248)

 



 


Other comprehensive (expense)/ income



(26)

169

 

Total comprehensive loss for the financial year attributable to owners of the parent



(1,877)

 

(1,079)

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME




 


for the financial year ended 31 December 2023 (continued)




 





2023

2022




 


(Loss)/earnings per share expressed in pence per share:



 


From continuing operations

- basic



(5.8)p

0.5p

- diluted



(5.8)p

0.5p




 





 


From discontinued operations

- basic



-p

(4.7)p

- diluted



-p

(4.7)p




 


 

 

 

 

 

 

 

 

 

 

 



 

Consolidated Statement of financial position

at 31 December 2023


 

 

2023

2022


 

 

£'000

£'000

Non-current assets

 

 

 


Goodwill


 

2,338

2,338

Intangible assets


 

             600

-

Property, plant and equipment


 

3,048

2,162

Biological assets


 

642

884



 

6,628

5,384

Current assets


 

 


Trade and other receivables


 

3,649

7,223

Inventories


 

1,044

316

Cash and cash equivalents


 

1,186

1,491

 


 

5,879

9,030

 


 

 


TOTAL ASSETS


 

12,507

14,414

 


 

 


Equity attributable to owners of the parent


 

 


Share capital


 

990

564

Share premium 


 

2,094

-

Other reserves


 

(94)

(68)

Retained earnings


 

3,353

5,204

TOTAL EQUITY


 

6,343

5,700

 


 

 


Non-current liabilities


 

 


Borrowings


 

932

1,016

Deferred tax


 

168

58



 

1,100

1,074

Current liabilities


 

 


Trade and other payables


 

3,826

3,427

Liabilities - discontinued operations


 

-

298

Borrowings


 

1,238

3,915



 

5,064

7,640



 

 


TOTAL EQUITY AND LIABILITIES


 

12,507

14,414

 


 

 



 

 


 

 



Consolidated Statement of Changes in Equity

 

For the financial year ended 31 December 2023

 


 

 

 

 

 


 

 

 

 

 

Share

Share

Other

Retained

 

 

capital

Premium

Reserves

Earnings

Total


£'000

£'000

£'000

£'000

£'000

At 1 January 2022

564

-

(237)

6,452

6,779

Loss for the financial year

 

-

-

-

(1,248)

(1,248)

Foreign exchange gain

-

-

169

-

169

 

Total comprehensive income for the financial year

-

-

169

(1,248)

(1,079)

Equity dividends paid

-

-

-

-

-







Transactions with owners

-

-

-

-

-

At 31 December 2022

564

-

(68)

5,204

5,700

 

 

 

 

 

 

Loss for the financial year

-

-

-

(1,851)

(1,851)

Foreign exchange loss

-

-

(26)


(26)

Total comprehensive income for the financial year

-

-

(26)

(1,851)

(1,877)

Issue of share capital

426

2,224

-

-

2,650

Share issue costs

-

(130)

-

-

(130)

Transactions with owners

 

426

2,094

(26)

(1,851)

643

At 31 December 2023

990

2,094

(94)

 

3,353

6,343

 



 

Consolidated Cash Flow Statement 

 for the financial year ended 31 December 2023

 

2023

 

2022



£'000

£'000

Cash flow from operating activities


 


(Loss)/profit on continuing activities before taxation


(1,801)

217

Gain on change in fair value of biological assets


(139)

(182)

Biological assets disposal


91

117

Foreign exchange gain


(382)

(201)

Loss on discontinued activities


-

(1,404)

Finance expenses


166

128

Finance income


-

(9)

Bad debt expense


15

41

Taxation charge


(12)

(40)

Impairment - Intangible asset


-

665

Depreciation - property, plant and equipment


187

191

Operating cash flows before changes in working capital


(1,875)

(477)

 


 


Changes in working capital and provisions:


 


Increase/ (decrease) in inventories


66

(218)

Increase/ (decrease) in trade and other receivables


4,826

(3,223)

Decrease in current liabilities held for sale


-

(1,571)

(Decrease)/ increase in payables


(1,212)

848

Taxation paid


(3)

(25)

Net cash from/(used in) from operating activities


3,677

(4,189)

 

Cash flow from investing activities


 


Payments to acquire subsidiary undertaking


(2,075)

-

Cash acquired as part of acquisition


299

-

Purchase of property, plant and equipment


(63)

(62)

Proceeds from sale of biological assets


272

149

Net cash used/generated from investing activities


(1,567)

87

 

Invoice finance utilised


(2,805)

1,649

Finance lease capital repayments


(69)

(91)

Term loan repayments


(36)

(31)

Net proceeds from issue of share capital


2,370

-

Net cash used/generated from financing activities


(540)

1,527

 


 


Net decrease in cash and cash equivalents


(305)

(3,052)

 

Cash and cash equivalents beginning of the financial year


1,491

4,543

Cash and cash equivalents end of the financial year


1,186

1,491

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FLFLIVFITFIS

1 Year Roebuck Food Group Public Chart

1 Year Roebuck Food Group Public Chart

1 Month Roebuck Food Group Public Chart

1 Month Roebuck Food Group Public Chart

Your Recent History

Delayed Upgrade Clock